IL-15 enhances survival and function of HIV-specific CD8+ T cells
- PMID: 12393488
- DOI: 10.1182/blood-2002-07-1957
IL-15 enhances survival and function of HIV-specific CD8+ T cells
Abstract
HIV-specific CD8(+) T cells are prone to undergo apoptosis, and this may affect their ability to control HIV infection. Because CD8-mediated immune responses play a key role in controlling HIV infection, enhancing the survival and effector function of HIV-specific CD8(+) T cells may augment their ability to control HIV virus. We show here that interleukin 15 (IL-15) potently inhibits spontaneous and CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. IL-15 inhibits apoptosis in both CD45RA(-)CD62L(-) and CD45RA(+)CD62L(-) effector memory subpopulations of these cells. Furthermore, IL-15 greatly enhances the survival of HIV-specific CD8(+) T cells in long-term cultures. Finally, IL-15 directly enhances activation, interferon gamma (IFNgamma) production, and direct ex vivo cytotoxicity of HIV-specific CD8(+) T cells. Thus, IL-15 potently enhances the survival and effector function of HIV-specific CD8(+) T cells and, therefore, may prove useful in augmenting the antiviral function of these cells.
Similar articles
-
IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells.Int Immunol. 2003 Jan;15(1):49-58. doi: 10.1093/intimm/dxg013. Int Immunol. 2003. PMID: 12502725
-
Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells.Immunity. 2001 Dec;15(6):871-82. doi: 10.1016/s1074-7613(01)00246-1. Immunity. 2001. PMID: 11754810
-
Profound enhancement of the IL-12/IL-18 pathway of IFN-gamma secretion in human CD8+ memory T cell subsets via IL-15.J Immunol. 2007 Apr 15;178(8):4786-92. doi: 10.4049/jimmunol.178.8.4786. J Immunol. 2007. PMID: 17404259
-
HIV-specific CD8+ T cells: serial killers condemned to die?Curr HIV Res. 2004 Apr;2(2):153-62. doi: 10.2174/1570162043484960. Curr HIV Res. 2004. PMID: 15078179 Review.
-
IL-15 is a growth factor and an activator of CD8 memory T cells.Ann N Y Acad Sci. 2002 Dec;975:46-56. doi: 10.1111/j.1749-6632.2002.tb05940.x. Ann N Y Acad Sci. 2002. PMID: 12538153 Review.
Cited by
-
Cytokine-adjuvanted HIV-DNA vaccination strategies.Springer Semin Immunopathol. 2006 Nov;28(3):231-8. doi: 10.1007/s00281-006-0047-y. Epub 2006 Oct 20. Springer Semin Immunopathol. 2006. PMID: 17053912 Review.
-
In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.J Virol. 2015 Jun;89(12):6264-74. doi: 10.1128/JVI.00563-15. Epub 2015 Apr 1. J Virol. 2015. PMID: 25833053 Free PMC article.
-
Current strategies against COVID-19.Chin Med. 2020 Jul 9;15:70. doi: 10.1186/s13020-020-00353-7. eCollection 2020. Chin Med. 2020. PMID: 32665783 Free PMC article. Review.
-
Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion.Infect Immun. 2004 Jul;72(7):3951-60. doi: 10.1128/IAI.72.7.3951-3960.2004. Infect Immun. 2004. PMID: 15213139 Free PMC article.
-
So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.Viruses. 2022 Jan 12;14(1):135. doi: 10.3390/v14010135. Viruses. 2022. PMID: 35062339 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous